What is the current Price Target for the AcelRx Pharmaceuticals, Inc. stock?

The average AcelRx Pharmaceuticals, Inc. target price is $3.57. This is 725.43% higher than the current stock price. The highest price target is 1,356.65%, the lowest is 600.58%. 5 Analysts have issued a price target AcelRx Pharmaceuticals, Inc. 2026 .

How high will the AcelRx Pharmaceuticals, Inc. stock rise?

No reliable answer can be given as to how high the AcelRx Pharmaceuticals, Inc. stock will rise. The performance of stocks, including the AcelRx Pharmaceuticals, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the AcelRx Pharmaceuticals, Inc. stock today?

The performance of AcelRx Pharmaceuticals, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the AcelRx Pharmaceuticals, Inc. stock fall?

The decline in AcelRx Pharmaceuticals, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

AcelRx Pharmaceuticals, Inc. Forecast, price target & analysts

$0.43

2.90% yesterday

Nasdaq, Aug 13, 10:00 pm CET

ISIN

US00444T1007

Symbol

TLPH

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

AcelRx Pharmaceuticals, Inc. Target price 2025 - Analyst rating & recommendation

AcelRx Pharmaceuticals, Inc. Classifications & Recommendation:

Buy

89%

Hold

11%

AcelRx Pharmaceuticals, Inc. Price Target

Target Price	$3.57
Price	$0.43
Potential	725.43% register free of charge
Number of Estimates	5

	5 Analysts have issued a price target AcelRx Pharmaceuticals, Inc. 2026 . The average AcelRx Pharmaceuticals, Inc. target price is $3.57. This is 725.43% register free of charge higher than the current stock price. The highest price target is $6.30 1,356.65% register free of charge , the lowest is $3.03 600.58% register free of charge .
	A rating was issued by 9 analysts: 8 Analysts recommend AcelRx Pharmaceuticals, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the AcelRx Pharmaceuticals, Inc. stock has an average upside potential 2026 of 725.43% register free of charge . Most analysts recommend the AcelRx Pharmaceuticals, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2024 Estimates
Earnings Per Share $	-0.50	-0.60
	60.94%
P/E		negative

AcelRx Pharmaceuticals, Inc....

Current AcelRx Pharmaceuticals, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Apr 01 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 21 2025

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Apr 01 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 21 2025

Discover more stocks with a high price target

Deutsche Telekom 27.63%

TUI 25.18%

BioNTech SE - ADR 24.36%

Alibaba Group Holding Ltd 24.23%

Microsoft 22.46%

Snowflake 19.16%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now